Jarlei Fiamoncini Selected Research

Jarlei Fiamoncini Research Topics

Disease

7	Obesity 10/2023 - 07/2012
6	Insulin Resistance 01/2023 - 10/2008
4	Body Weight (Weight, Body) 01/2023 - 07/2012
3	Necrosis 09/2012 - 10/2008
2	Liver Diseases (Liver Disease) 10/2023 - 10/2015
2	Inflammation (Inflammations) 01/2023 - 07/2012
2	Weight Gain 12/2022 - 02/2022
2	Weight Loss (Weight Reduction) 11/2018 - 10/2017
2	Metabolic Diseases (Metabolic Disease) 12/2016 - 02/2014
2	Non-alcoholic Fatty Liver Disease 10/2015 - 08/2014
2	Glucose Intolerance 08/2015 - 02/2014
1	Overnutrition 12/2023
1	Fatty Liver 10/2023
1	Hypertrophy 02/2022
1	Overweight 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Anemia 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Dyslipidemias (Dyslipidemia) 08/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2014
1	Neoplasms (Cancer) 09/2014
1	Hyperlipidemias (Hyperlipidemia) 06/2013
1	Muscular Atrophy (Muscle Atrophy) 06/2010
1	Critical Illness (Critically Ill) 01/2008

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2013
4	Insulin (Novolin)FDA Link 01/2023 - 10/2008
4	LipidsIBA 10/2018 - 01/2008
3	Bile Acids and Salts (Bile Acids)IBA 11/2018 - 12/2016
2	Triglycerides (Triacylglycerol)IBA 10/2023 - 02/2014
2	Leucine (L-Leucine)FDA Link 01/2023 - 06/2010
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2015 - 02/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012 - 10/2008
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2023
1	Serotonin (5 Hydroxytryptamine)IBA 12/2023
1	TeaIBA 10/2023
1	PolyphenolsIBA 10/2023
1	AntioxidantsIBA 10/2023
1	Amino Acids FDA Link 01/2023
1	Monoterpenes (Monoterpenoids)IBA 01/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	LimoneneIBA 12/2022
1	PhytochemicalsIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	C-Reactive ProteinIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	L 35 (L35)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2018
1	Cholic AcidIBA 12/2016
1	EnzymesIBA 10/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2015
1	lardIBA 08/2015
1	SeleniumIBA 09/2014
1	CarbonIBA 08/2014
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2014
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 02/2014
1	Acyl Coenzyme A (Acyl CoA)IBA 02/2014
1	Blood Glucose (Blood Sugar)IBA 02/2014
1	Acetyl-CoA CarboxylaseIBA 02/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2014
1	Fish OilsIBA 06/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2012
1	InterleukinsIBA 09/2012
1	CytokinesIBA 09/2012
1	tributyrinIBA 07/2012
1	ProdrugsIBA 07/2012
1	Palmitic Acid (Hexadecanoic Acid)IBA 07/2012
1	Butyrates (Butyrate)IBA 07/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2010
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2010
1	Insulin Receptor Substrate ProteinsIBA 10/2008
1	NF-kappa B (NF-kB)IBA 10/2008
1	Protein Kinase CIBA 10/2008
1	Proteins (Proteins, Gene)FDA Link 10/2008
1	EmulsionsIBA 01/2008

Therapy/Procedure

1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2018